Urrets- Zavalia Syndrome after glaucoma filtration device implantation

Clin Ter. 2013;164(5):e381-2. doi: 10.7417/CT.2013.1617.

Abstract

We report a case of Urrets-Zavalia Syndrome after a glaucoma filtration device (g.f.d.) implantation. A 74-year-old woman with bilateral advanced glaucoma has been planned for surgery. The patient underwent to g.f.d. implantation in the right eye. On postoperative day 1, the patient had an edematous cornea with a dilated and non reactive pupil. In this article we describe the clinical history of this patient. To our knowledge, this is the first case of Urrets-Zavalia Syndrome after a g.f.d. implantation.

MeSH terms

  • Acetazolamide / administration & dosage
  • Acetazolamide / therapeutic use
  • Aged
  • Brimonidine Tartrate
  • Cataract Extraction
  • Combined Modality Therapy
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Glaucoma Drainage Implants / adverse effects*
  • Glaucoma, Open-Angle / complications
  • Glaucoma, Open-Angle / drug therapy
  • Glaucoma, Open-Angle / surgery
  • Humans
  • Hypertension / complications
  • Miotics / pharmacology
  • Mydriasis / etiology*
  • Ocular Hypertension / drug therapy
  • Ocular Hypertension / etiology
  • Pilocarpine / administration & dosage
  • Pilocarpine / therapeutic use
  • Prostaglandins F / administration & dosage
  • Prostaglandins F / therapeutic use
  • Quinoxalines / administration & dosage
  • Quinoxalines / therapeutic use
  • Sulfonamides / administration & dosage
  • Sulfonamides / therapeutic use
  • Syndrome
  • Thiophenes / administration & dosage
  • Thiophenes / therapeutic use
  • Timolol / administration & dosage
  • Timolol / therapeutic use

Substances

  • Miotics
  • Prostaglandins F
  • Quinoxalines
  • Sulfonamides
  • Thiophenes
  • Pilocarpine
  • tafluprost
  • Brimonidine Tartrate
  • Timolol
  • dorzolamide
  • Acetazolamide